Clinical Services

Towards zero lives lost to blood cancer

02 October, 2020

The National Strategic Action Plan for Blood Cancer aims to unite Australia towards the goal of zero lives lost to blood cancer by 2035.

When a basin becomes the difference between life and death

02 October, 2020 | Supplied by: Gentec Australia

After significant research and development, Gentec has launched a range of healthcare basins specifically designed to prevent infections by offsetting the drain hole.

Summing up health costs of the last bushfire season

01 October, 2020

Australian researchers have found that the 2019–2020 bushfire season racked up smoke-related health costs of around $1.95 billion.

Whiteley Corporation Viraclean hospital-grade disinfectant

01 October, 2020 | Supplied by: Whiteley

The infection-control product is designed to defend against SARS-CoV-2 (the virus that causes COVID-19), which may be present on healthcare surfaces.

InovaAir AirClean DE20 PLUS Air Purifier

01 October, 2020 | Supplied by: InovaAir Australia Pty Ltd

The AirClean DE20 Plus from InovaAir is a medical-grade H13 HEPA air purifier that filters 99.95% at 0.3 microns efficiency.

Breast cancer study calls for twins

01 October, 2020

Melbourne identical twins have joined a major new study investigating why only one twin in a pair develops breast cancer, or if both twins are diagnosed, why one twin does so earlier.

Why do some people develop life-threatening COVID-19?

30 September, 2020

More than 10% of healthy people who develop severe COVID-19 produce misguided antibodies that attack the patient's own immune system.

Tarantula venom could hold key to IBS pain relief

29 September, 2020

Molecules from the venom of one of the world's largest spiders could be used to develop pain blockers for people with irritable bowel syndrome.

Coffee drinking confers benefits in cancer study

23 September, 2020

Daily coffee consumption has been associated with improved survival in patients with metastatic colorectal cancer, according to a study led by Dana-Farber Cancer Institute.

Report finds high use of antimicrobials in major cities

23 September, 2020

Sustained high use of antimicrobial medicines has been demonstrated in a five-year trend report released by the Australian Commission on Safety and Quality in Health Care.

Report reveals burden of non-melanoma skin cancer

18 September, 2020

A new report has revealed the unseen burden of non-melanoma skin cancer in Australia.

Study finds pregnancy can delay onset of MS symptoms

17 September, 2020

A Monash-led international study has found that pregnancy can delay the onset of multiple sclerosis symptoms by more than three years.

Cochrane Review finds individualised treatment best for PCOS

11 September, 2020

The study compared the two most common treatments used in the long-term medical management of the condition: the oral contraceptive pill and metformin.

Gout treatment halts coronary disease progression

09 September, 2020

A trial has found that heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients taking low-dose colchicine, a drug commonly used to treat gout.

Queensland and Oxford: a tale of two vaccine agreements

08 September, 2020

CSL Limited has signed a heads of agreement for the supply of UQ's COVID-19 vaccine candidate and another to manufacture Oxford University's candidate.

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd